Suppliers / Guizhou Utide Biotechnology

Guizhou Utide Biotechnology

China Updated 9 July 2026

Guizhou Utide Biotechnology is a contract manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Questions about Guizhou Utide Biotechnology

Does Guizhou Utide Biotechnology hold a US DMF or a CEP?
Guizhou Utide Biotechnology holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Guizhou Utide Biotechnology make?
2 molecules are on record against Guizhou Utide Biotechnology, including Retatrutide and Tirzepatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Check Guizhou Utide Biotechnology's supplier records

Review its manufacturing sites and inspection history in PharmaDB.

Sign up free
Free with a work email. No password.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability